Compare BridgeBio Pharma Inc (BBIO) vs Core and Main Inc (CNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Core and Main Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Core and Main Inc trades at $46.73 (market cap $8.73B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Core and Main Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | CNM | |
|---|---|---|
Market Cap | $16.36B | $8.73B |
Sector | Health | Technology |
52-Week High | $90.17 | $66.98 |
52-Week Low | $47.29 | $42.37 |
Enterprise Value | $18.14B | $11.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Core and Main Inc
Core & Main is a leading US distributor of water, wastewater, storm drainage, and fire protection products. It provides essential infrastructure solutions to municipalities, private water companies, and contractors.
Read more on CNM →
